Iris Lin
Overview
Explore the profile of Iris Lin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
181
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xie F, Fassett M, Shi J, Chiu V, Im T, Kim S, et al.
Am J Perinatol
. 2024 Nov;
PMID: 39532115
Objective: This study aims to identify hemolytic disease of the fetus and newborn (HDFN) pregnancies using electronic health records (EHRs) from a large integrated health care system. Study Design: A...
2.
Lin I, Krupsky K, Way N, Patel A, Tieng A
Rheumatol Ther
. 2024 Sep;
11(6):1569-1590.
PMID: 39343841
Introduction: Psoriatic arthritis (PsA) is a chronic, autoimmune form of arthritis that is associated with a substantial humanistic and economic burden. Potential differences in patient-reported outcomes (PROs) and economic outcomes...
3.
Walsh J, Lin I, Zhao R, Shiff N, Morrison L, Emond B, et al.
Drugs Real World Outcomes
. 2024 Jul;
11(3):487-499.
PMID: 39083163
Background: Treatment persistence among patients with psoriatic arthritis (PsA) is essential for achieving optimal treatment outcomes. Guselkumab, a fully human interleukin-23p19-subunit inhibitor, was approved by the United States (US) Food...
4.
Yim I, Zhang L, Lin I, Laronde D
Can J Dent Hyg
. 2024 Jul;
58(2):98-105.
PMID: 38974821
Objective: Oral lichen planus (OLP) is an immune-mediated condition featuring chronic inflammation. The World Health Organization classifies OLP as potentially malignant, but it is believed that the malignant transformation of...
5.
Murakhovskaya I, Crivera C, Leon A, Alemao E, Anupindi V, DeKoven M, et al.
Ann Hematol
. 2024 Jan;
103(4):1139-1147.
PMID: 38296903
This retrospective cohort study described real-world treatment patterns and healthcare resource utilization (HCRU) of patients with warm autoimmune hemolytic anemia (wAIHA) initiating treatment with first-line (1L) oral corticosteroids (OCS) + ...
6.
Palmer D, Cayton C, Scott A, Lin I, Newell B, Paulson A, et al.
Cell Rep
. 2024 Jan;
43(1):113669.
PMID: 38194343
Reward-predictive cues acquire motivating and reinforcing properties that contribute to the escalation and relapse of drug use in addiction. The ventral pallidum (VP) and ventral tegmental area (VTA) are two...
7.
Lin I, Armengou-Garcia L, Sasikumar S, Kuhlman G, Fox S, Lang A, et al.
Mov Disord Clin Pract
. 2023 Sep;
10(9):1408-1413.
PMID: 37772280
Background: Amantadine is a widely prescribed medication in Parkinson's disease (PD). A distinctive craniofacial distribution of myoclonus with speech impairment is an underrecognized iatrogenic complication in amantadine-treated patients with PD....
8.
Mease P, Ogdie A, Tesser J, Shiff N, Lin I, Chakravarty S, et al.
Rheumatol Ther
. 2023 Aug;
10(6):1479-1501.
PMID: 37597159
Introduction: The aim of this work is to evaluate treatment persistence and clinical outcomes after 6 months of on-label guselkumab use in patients with rheumatologist-diagnosed active psoriatic arthritis (PsA) enrolled...
9.
Patel A, Ferrante S, Lin I, Fu A, Campbell A, Tieng A
Rheumatol Ther
. 2023 Jul;
10(5):1241-1253.
PMID: 37453020
Introduction: In patients with psoriatic arthritis (PsA), potential differences in care by race/ethnicity have not been well studied. Methods: This retrospective, observational cohort analysis utilized the IBM MarketScan Multi-State Medicaid...
10.
Scott A, Palmer D, Newell B, Lin I, Cayton C, Paulson A, et al.
J Neurosci
. 2023 Jun;
43(28):5191-5203.
PMID: 37339880
Reward-seeking behavior is often initiated by environmental cues that signal reward availability. This is a necessary behavioral response; however, cue reactivity and reward-seeking behavior can become maladaptive. To better understand...